AstraZeneca sees big healthcare changes under Trump
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
AstraZeneca (AZN) Tops Q3 EPS by 6c
November 10, 2016 8:27 AM ESTAstraZeneca (NYSE: AZN) reported Q3 EPS of $0.80, $0.06 better than the analyst estimate of $0.74. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.95 billion.
Pascal Soriot, Chief Executive Officer, commenting on the results said:
The performance in the third quarter was in line with our expectations,... More
